Navigation Links
NIH grant to Emory and pediatric partners aims to improve kidney transplants for children
Date:3/11/2008

Emory University School of Medicine and Children's Healthcare of Atlanta are teaming up with two university hospitals in California to find new ways to make kidney transplants more tolerable for children.

Emory and Children's will partner with UCLA's Mattel Childrens Hospital in Los Angeles and Lucile Packard Children's Hospital at Stanford in Palo Alto for a study of kidney transplants in children.

The National Institutes of Health has awarded the partner institutions a five-year grant totaling approximately $6 million for Clinical Trials in Organ Transplantation in Children (CTOT-C).

In the last decade, doctors have been able to refine the regimens of drugs given to transplant patients. Successful transplantation depends on immunosuppressant drugs to prevent tissue rejection, but the drugs bring multiple side effects such as kidney disease and an increased risk of cardiovascular disease.

"Most anti-rejection drugs were developed in adults and are adapted for children by simply adjusting for weight," says Allan Kirk, MD, PhD, scientific director of the Emory Transplant Center and the study's leader. "But the immune system doesnt grow in parallel with a child's weight. The result is that children are often over-immunosuppressed."

Coordinating work among the three university hospitals will allow the study to encompass a group of patients that spans various demographic groups and national origins, says Dr. Kirk, who is a professor of surgery and pediatrics at Emory School of Medicine, a Georgia Research Alliance Eminent Scholar, and an attending surgeon at Children's Healthcare of Atlanta.

As children mature and are gradually exposed to various environmental stresses, such as viral infections, the set of T cells (white blood cells) they have in their bodies that are able to respond to infections or other outside agents changes.

Part of the CTOT-C program will catalog and define how pediatric kidney transplant patients' T cell repertoires evolve as they get older.

The team plans to develop ways to "fingerprint" the pediatric patients' immune systems with information on which genes are turned on and off in their white blood cells. With that information as a diagnostic tool, therapy could be tailored to an individual child at a given point in time, Dr. Kirk says.

"The good news is that outcomes in kidney transplantation have become much more successful in the last couple of decades," says Barry Warshaw, MD, chief of pediatric nephrology at Children's Healthcare of Atlanta and associate professor of pediatrics at Emory. "The bad news is that kidney transplants still dont last a lifetime."

Dr. Warshaw says one of the key aims of the clinical studies will be to develop a simple blood or urine test to inform doctors whether kidney rejection is "revving up," possibly avoiding painful biopsies.

"We're very excited about this grant and expect that it will one day be seen as a landmark in pediatric renal transplantation," he says.


'/>"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University
Source:Eurekalert

Related medicine news :

1. Burroughs Wellcome Fund grants $9.75 million towards translational researchers
2. Mass. General Hospital receives Gates Foundation grant to expand HIV controllers study
3. Doug Flutie, Jr. Foundation Grants NAA $10,000 for Burbacher/Charleston Study
4. NYU College of Nursing researcher awarded $4.1M grant to study nurses work decisions
5. Highmark Inc. Supports Employee Volunteerism Efforts with $5,500 in Community Grants
6. Alzheimers Foundation of America Awards Grants to Local Groups Nationwide
7. AMA Foundation Announces Seed Grant Research Recipients
8. FDA Grants Over-The-Counter Clearance to GentleWaves(R) for the First Home Use Light-Based Device to Treat Wrinkles
9. EPA Funds Grants for Lead Poisoning Prevention Projects in Two Wisconsin Communities
10. EPA Funds Grants for Four Lead Poisoning Prevention Projects in Michigan Communities
11. EPA Funds Grants for Lead Poisoning Prevention Projects in Two Ohio Communities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... ... , ... "Success Files," a short- and long-form documentary style ... disease estimated to affect the lives of more than 5 million Americans living ... leading voice in the fight for cure and research into the disease, its ...
(Date:9/22/2017)... ... 2017 , ... Egg freezing and embryo freezing are both ... slight statistical advantage for live births, frozen eggs offer many advantages, depending on ... medical treatment or who are concerned about the decline of their fertility as ...
(Date:9/21/2017)... ... 2017 , ... SABRE is raising awareness about personal safety with a Chicago ... November. , The Chicago, Illinois, based self-defense brand has been waiting for an opportunity ... of taking their personal safety into their own hands. , The ads focus on ...
(Date:9/21/2017)... (PRWEB) , ... September 21, 2017 , ... Bill Howe ... to its customers, and give back to the community. For over 37 years, they ... most successful companies serving plumbing in San Diego. They were chosen as ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, ... Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East ... pieces, such as Zen Kodo mat. Wanderlust , one of the largest US ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... JERUSALEM , Sept. 5, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage pharmaceutical company focused on the ... it has successfully concluded its meeting with the U.S. ... novel oral insulin formulation. ... that the regulatory pathway for submission of ORMD-0801, would ...
(Date:8/29/2017)... 29, 2017 ivWatch, LLC, the leading provider of continuous ... it has been awarded an Innovative Technology contract from Vizient, Inc., ... ... aid in the early detection of peripheral IV infiltration and extravasation ... The Innovative Technology contract was awarded ...
Breaking Medicine Technology: